By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Active Biotech AB 

Scheelevägen 22

Lund    SE-220 07  Sweden
Phone: 46-46-19-10-00 Fax: 46-46-19-20-50




Company News
Teva Pharmaceutical Industries Limited (TEVA) And Active Biotech AB (BTPC) Announce Expansion Of Laquinimod Clinical Development Program With New Trial In Primary Progressive Multiple Sclerosis And First Patient Screened In Huntington’s Disease Trial 11/4/2014 10:29:23 AM
Active Biotech AB (BTPC) Presents Data On Paquinimod At EULAR 2014 6/11/2014 7:26:41 AM
Active Biotech AB (BTPC) To Present At Jefferies and Co. 2014 Healthcare Conference 6/3/2014 9:02:17 AM
Despite Rejection, Teva Pharmaceutical Industries Limited (TEVA) And Active Biotech AB (BTPC) Remain Committed To The Development Of Multiple Sclerosis Nerventra® 5/23/2014 6:48:57 AM
Annual General Meeting Of Active Biotech AB (BTPC) 5/16/2014 10:03:14 AM
Active Biotech AB (BTPC) Interim Report January - March 2014 4/24/2014 9:21:42 AM
Active Biotech AB (BTPC) - Notice Of Annual General Meeting Of Shareholders 4/14/2014 8:53:51 AM
Annual Report 2013 Active Biotech AB (BTPC) 4/7/2014 9:12:53 AM
Active Biotech AB (BTPC) Release: Change In The Clinical Development Program For Laquinimod 2/19/2014 8:54:08 AM
Active Biotech AB (BTPC) Year-End Report January - December 2013 2/13/2014 9:40:24 AM